rs281865443
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000277.3(PAH):c.632C>T(p.Pro211Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,808 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P211T) has been classified as Pathogenic.
Frequency
Consequence
NM_000277.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAH | NM_000277.3 | c.632C>T | p.Pro211Leu | missense_variant | 6/13 | ENST00000553106.6 | NP_000268.1 | |
PAH | NM_001354304.2 | c.632C>T | p.Pro211Leu | missense_variant | 7/14 | NP_001341233.1 | ||
PAH | XM_017019370.2 | c.632C>T | p.Pro211Leu | missense_variant | 6/7 | XP_016874859.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAH | ENST00000553106.6 | c.632C>T | p.Pro211Leu | missense_variant | 6/13 | 1 | NM_000277.3 | ENSP00000448059.1 | ||
PAH | ENST00000549111.5 | n.728C>T | non_coding_transcript_exon_variant | 6/6 | 1 | |||||
PAH | ENST00000307000.7 | c.617C>T | p.Pro206Leu | missense_variant | 7/14 | 5 | ENSP00000303500.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461808Hom.: 0 Cov.: 34 AF XY: 0.00000138 AC XY: 1AN XY: 727204
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Phenylketonuria Pathogenic:6
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 16, 2023 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Mar 16, 2018 | - - |
Likely pathogenic, no assertion criteria provided | literature only | Inserm U 954, Faculté de Médecine de Nancy | - | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 17, 2019 | Variant summary: PAH c.632C>T (p.Pro211Leu) results in a non-conservative amino acid change in the catalytic domain (IPR041912) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251336 control chromosomes (gnomAD). c.632C>T has been reported in the literature in individuals affected with Phenylalanine Hydroxylase Deficiency (Phenylketonuria) (Gundorova_2016, Bik-Multanowski_2013). These data indicate that the variant may be associated with disease. Two ClinVar submissions (evaluation after 2014) cite the variant as likely pathogenic. In addition, another variant affecting the same codon, P211T, along with variants nearby, N207S, L213P, E214G, have been reported to be associated with PKU. Therefore, suggesting the region is important for protein function. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Likely pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Jul 13, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 211 of the PAH protein (p.Pro211Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with classic phenylketonuria and PAH deficiency (PMID: 24350308; Invitae). ClinVar contains an entry for this variant (Variation ID: 120283). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PAH protein function with a positive predictive value of 80%. This variant disrupts the p.Pro211 amino acid residue in PAH. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 8268925, 9429153, 11708866, 16198137, 17935162, 23500595). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at